<!DOCTYPE html>
<html lang="en" dir="ltr">
  <head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="style.css">
    <title>List Styling</title>
  </head>
  <body>
    <main>
      <article>
        <hgroup>
          <h2>Mahacef</h2>
          <p>(Cefixime)</p>
        </hgroup>

        <h3>name of medicinal product</h3>
        <p><b>Mahacef-100</b> (Cefixime Dispersible Tablets 100mg) </p>
        <p><b>Mahacef-100</b> (Cefixime Tablets USP 100mg) </p>

        <h3>qualitative and quantitative composition</h3>
        <p><b>Mahacef-100:</b> Each dispersible tablet contains Cefixime (as Tryhydrate) USP equivalent to Anhydrous Cefixime 200 mg</p>
        <p><b>Mahacef-100:</b> Each film coated tablet contains Cefixime (as Tryhydrate) USP equivalent to Anhydrous Cefixime 200 mg</p>

        <h3>pharmaceutical forms</h3>
        <p><b>Mahacef-100:</b> Light pink coloured, round, flat, uncoated, mottled tablet, scored on one side.</p>
        <p><b>Mahacef-200:</b> Dark red coloured, elongated, biconvex, film coated tablets, scored on one side.</p>

        <h3>clinical particulars</h3>

        <h4>Therapeutic indications</h4>
        <p>Cefixime is an orally active cephalosporin antibiotic which has marked <i>in vitro</i> bactericidal activity against a wide variety of Gram-positive and Gram-negative organism.</p>
        <p>It is indicated for the treatment of the following acute infections when caused bu susceptible microorganisms:</p>
        <p><b>Upper Respiratory Tract Infections (URTI):</b> e.g. otitis media; and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk.</p>
        <p><b>Lower Respiratory Tract Infections</b> e.g. bronchitis.</p>
        <p><b>Urinary Tract  Infections</b> e.g. cystitis, cystourethritis, uncomplicated pyelonephritis.</p>
        <p>Clinical efficacy has bee demonstrated in infections caused by commonly occuring pathogens including <i>Streptococcus pneumooniae</i>, <i>Streptococcus pyogenes</i>, <i>Escherichia coli</i>, <i>Proteus mirabilis</i>, <i>Kliebsiella species</i>, <i>Haemophilus inflienzae</i> (beta-lactamase positive and negative), <i>Branhamella catarrhalis</i> (beta-lactamase positive and negative), and <i>Enterobacter species</i>. Cefixime is highly stable in the presence of beta-lactamase enzymes.</p>
        <p>p p p p p p p p p p p p p</p>
        <h4>Dosage and Administration</h4>
        <p>Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.</p>

        <h4>Contraindications</h4>
        <p>Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.</p>

        <h4>Special Warnings and Precuations for use</h4>
        <p>Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.</p>
        
        <h3>Pharmacological Properties</h3>

        <h4>Pharmacodynamic Properties</h4>

<h4>Pharmacodynamic Properties</h4>

<h4>Pharmacodynamic Properties</h4>

<h4>Pharmacodynamic Properties</h4>
        
        <h3>ht</h3>

        <h4>Pharmacodynamic Properties</h4>

<h4>Pharmacodynamic Properties</h4>

<h4>Pharmacodynamic Properties</h4>
        
        <h3>date of publication of insert</h3>
        <p><time datetime="2016-04">Aprril, 2026</time></p>

        <section>
            <p>Manufactured b:</p>
            
            <h3>Copmed Pharmaceutical Pvt. Ltd.</h3>
            <p>
              Unit-II, Plot No. 50, Gonpur<br>
              Industrial Area, Paonta Sahib, Dist. Simour,<br>
              Himachal Pradesh-173025 (INDIA))
            </p>
          </section>
        <section>
          <figure>
            <img src="" alt="">
            <figcaption>Mankind pharma logo</figcaption>
          </figure>
          <p>Manufactured for:</p>
          
          <h3>Mankind pharma Ltd.</h3>
          <p>
            208, Okhla Industrial Estate, Phase-3,<br>
          New Delhi-110 020 (INDIA)
        </p>

        </section>

      </article>

      <div class="colormix">
        <div style="--r:0;--c:cyan"></div>
        <div style="--r:1;--c:magenta"></div>
        <div style="--r:2;--c:yellow"></div>
      </div>
    </main>
  </body>
</html>
